All GP articles – Page 5
-
NewsNICE recommends abemaciclib for advanced breast cancer
New draft guidance from NICE recommends twice-daily abemaciclib with fulvestrant for adults with hormone receptor-positive, HER2-negative breast cancer
-
News
Three quarters of UK adults receive both doses of a COVID-19 vaccine
The latest data show that 60,000 deaths and 66,900 hospitalisations have been prevented by the COVID-19 vaccination programme, which continues to be rolled out
-
PHE/DH/DWP guideline
PHE COVID-19 vaccination guidance
A concise summary of guidance for healthcare professionals about the COVID-19 vaccination programme
-
Sponsored algorithm
Primary care management of iron deficiency anaemia
This management algorithm has been commissioned and funded by Norgine Pharmaceuticals Ltd and developed in partnership with Guidelines. Information intended for UK healthcare professionals only.
UK-HAE-FER-2100104
Date of preparation: July 2021 -
News
New guidance on COVID-19 vaccination in pregnancy issued by RCOG and RCM
The new resources assist healthcare professionals to promote COVID-19 vaccination to pregnant women
-
News
Public Health England updates flu vaccine resources for 2021–2022
Public Health England has updated documents summarising information on available flu vaccines and which flu vaccines children and young people should receive
-
News
Cancer-related cognitive impairment in men with prostate cancer
Study findings suggest patients’ subjective concerns of cancer-related cognitive impairment appear to be critical to patient outcomes
-
NICE guideline
COVID-19 rapid guideline on VITT
This Guidelines summary covers vaccine-induced immune thrombocytopenia and thrombosis, a syndrome that has been reported in rare cases after COVID-19 vaccination
-
News
New report on long COVID published by ONS
The report aims to answer questions on the prevalence of, and demographics and risk factors for long COVID, and to answer more questions in the future
-
News
Junior doctors questioned on industrial action over pay
Junior doctors in England will be polled on whether they are prepared to take industrial action supporting an enhanced pay rise
-
News
Consultation on increasing front-line access to drug overdose medication
Legislative changes are planned to make the opioid antagonist naxalone available to more healthcare workers and in more settings
-
PHE/DH/DWP guideline
PHE flu immunisation 2021–2022 guideline
This Guidelines summary covers key information on the 2021–2022 flu immunisation programme
-
News
NHS chief executive urges vaccination in young people
New NHS chief executive Amanda Pritchard has issued a statement urging young people to be vaccinated against COVID
-
News
Median illness duration is positively associated with age in school-aged children with COVID-19
A new study of school-aged children in the UK has shown that median illness duration is longer in children aged 12–17 years than in children aged 5–11 years
-
News
REACT study: COVID-19 infection rates three times lower for double vaccinated
Findings from the latest REACT-1 study show COVID-19 infection rates are three times lower for double vaccinated people
-
News
Drug-related deaths reach record high
Drug-related deaths in England and Wales reached their highest level in 2020, while Scotland’s drug-related death rate was 3.5 times higher than the UK overall
-
News
First drug approved under NICE fast-track pilot scheme
The fast-track appraisal process is being piloted by NICE for the review of selected low-risk appraisals
-
News
COVID-19 jabs expected to be approved for 16- and 17-year-olds
New advice is expected to approve COVID-19 vaccinations for healthy 16- and 17-year-olds
-
News
New study launched to investigate optimum COVID-19 vaccine dose interval in pregnant women
The Preg-CoV study will examine the immune response to COVID-19 vaccination at different dose intervals in pregnant women
-
News
Does vitamin D supplementation reduce the severity of IBS symptoms? An RCT answers
A new randomised controlled trial found no evidence to support the role of vitamin D in the management of irritable bowel syndrome symptoms or improving quality of life
